GO
Loading...

Pfizer Inc

More

  • Final Glance: Pharmaceuticals companies Monday, 23 Feb 2015 | 6:04 PM ET

    Baxter International Inc. rose$. 74 or 1.1 percent, to $68.64. Bristol-Myers Squibb Co. rose$. 77 or 1.3 percent, to $61.29. Eli Lilly& Co. fell$. 79 or 1.1 percent, to $71.09.

  • Most active New York Stock Exchange-traded stocks Monday, 23 Feb 2015 | 1:20 PM ET

    NEW YORK— A look at New York Stock Exchange 10 most-active stocks at the close of trading:. AT&T Inc. fell. 7 percent to $33.85 with 22,428,700 shares traded. Bank of America Corp. fell 1.1 percent to $16.20 with 69,059,000 shares traded.

  • Midday Glance: Pharmaceuticals companies Monday, 23 Feb 2015 | 1:20 PM ET

    Baxter International Inc. rose$. 72 or 1.1 percent, to $68.62. Bristol-Myers Squibb Co. rose$. 65 or 1.1 percent, to $61.17. Eli Lilly& Co. fell$. 99 or 1.4 percent, to $70.89.

  • Early Glance: Pharmaceuticals companies Monday, 23 Feb 2015 | 10:40 AM ET

    Baxter International Inc. rose$. 63 or. 9 percent, to $68.53. Bristol-Myers Squibb Co. rose$. 17 or. 3 percent, to $60.69. Eli Lilly& Co. fell$. 65 or. 9 percent, to $71.23.

  • Surging dollar takes bite out of US corporate profits Saturday, 21 Feb 2015 | 12:06 AM ET

    NEW YORK— The biggest obstacle for Coca-Cola and Pepsi these days isn't tied to taste tests, the declining popularity of sugary drinks or even their century-long rivalry. Global corporations from Avon Products to Yum Brands have said their quarterly results would have been much better if it hadn't been for the rising dollar. "It has really hit earnings," said Jack...

  • PARIS, Feb 20- Sanofi's new boss Olivier Brandicourt could earn up to 4.2 million euros a year at the drugs group and pocket an extra 4 million euros within 12 months as a one-off golden handshake. Brandicourt will also get 220,000 stock options and 45,000 performance shares a year in Sanofi, matching Viehbacher's award. He has a higher cash earnings potential...

  • Early movers: DE, ABBV, WMT, DSW, YHOO & more Friday, 20 Feb 2015 | 7:54 AM ET
    A trader works on the floor of the New York Stock Exchange.

    Some of the names on the move ahead of the open.

  • PARIS, Feb 19- French drugmaker Sanofi on Thursday named Olivier Brandicourt, a Paris- educated doctor and head of Bayer AG's healthcare arm, as its chief executive officer. Brandicourt had been widely tipped to become Sanofi's new boss, a position that opened when Chris Viehbacher was suddenly sacked last year. "Olivier Brandicourt's strong experience...

  • LOS ANGELES, Feb 19- As U.S. drugmakers face growing resistance to the high price of cutting-edge treatments, a handful of companies are working on a new payment model that rewards them for the long-term performance of their medicines. They include BioMarin Pharmaceutical Inc in San Rafael, California, and Sangamo BioSciences Inc in Richmond, California.

  • Sanders, top opposition member on the U.S. Senate Budget Committee, released a report decrying what he called "legalized tax fraud." Using the Cayman Islands, Bermuda and other tax havens, these companies have saved more than $280 billion in tax liabilities, Sanders concluded in the report. The senator from Vermont delivered his broadside a day ahead of a media...

  • Feb 17- CVS Health on Monday warned that costs of a potent new class of cholesterol treatments and other specialty drugs in development could eclipse those of expensive new medicines and overwhelm the healthcare system "if rigid cost control mechanisms are not put in place." CVS' call for cost controls follows sharp criticism from insurers, other payers and...

  • BOSTON, Feb 13- A massive effective devaluation of Venezuela's bolivar currency will likely badly dent 2015 earnings at a swath of major U.S. companies. Currently those assets are valued based on the main official rate of 6.3 bolivars to the dollar, or a second rate at 12 bolivars. Some companies, such as diapers and tissue maker Kimberly-Clark Corp, had recently...

  • Deal stocks rise, emboldening bankers, bull run Friday, 13 Feb 2015 | 12:16 PM ET

    Something unusual is happening this year when one company announces it is buying another. Shares of the acquirer are going up.

  • Between men and women, the better investors are... Friday, 13 Feb 2015 | 7:00 AM ET

    An exclusive analysis of more than 2.5 million portfolios tracked by SigFig found that, on average, women outperformed male investors.

  • Your first trade for Thursday Wednesday, 11 Feb 2015 | 6:26 PM ET

    The "Fast Money" traders give their final trades of the day.

  • Your first trade for Wednesday Tuesday, 10 Feb 2015 | 6:20 PM ET

    The "Fast Money" traders give their final trades of the day.

  • A trader works on the floor of the New York Stock Exchange.

    U.S. stocks closed up about 1 percent as investors shook off early negative news out of Greece on hopes of a resolution.

  • Early movers: KO, CVS, HOT, HD, GPS & more Tuesday, 10 Feb 2015 | 7:51 AM ET
    Traders work on the floor of the New York Stock Exchange, Feb. 9, 2015.

    Some of the names on the move ahead of the open.

  • WASHINGTON, Feb 10- For the first time in 20 years, patients suffering from the eye disease glaucoma may soon have new treatments as several young companies look to shake up the $5.6 billion global market. No new class of medicine has been introduced since Pfizer Inc's N> Xalatan, known generically as latanoprost, in 1996.. The newcomers aim to disrupt...

  • Feb 9- Drugmaker Pfizer Inc said it entered into an agreement with Goldman, Sachs& Co to buy back $5 billion of its stock. Pfizer said the accelerated share repurchase was assumed in the forecast for the full year it provided last month. Under the agreement, which forms a part of Pfizer's existing buyback authorization, about 150 million shares will be bought.